AtriCure (ATRC) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $34.80 --0%
EPS Growth %: +92.3%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
CCEL, FNGR, FAST, More
EPS Growth %: +92.3%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $37.85 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Soluna added to Russell indexes, signs LOI for 350 MW AI project
- Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
